Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (7.900)
1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma : Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, Rituximab (TEDDI-R) in Primary CNS Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors : Phase I Trial of the Combination of Bortezomib and Clofarabine in Adults With Refractory Solid Tumors, Lymphomas, or Myelodysplastic Syndromes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration : A Phase 1b, Multicenter, Dose Escalation, Evaluation of Safety and Tolerability of ASP7317 for Geographic Atrophy Secondary to Age-related Macular Degeneration
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. : A Pilot Study of a Personalized Neoantigen Cancer Vaccine With and Without Low-Dose Cyclophosphamide or Pembrolizumab in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated Chronic Lymphocytic Leukemia.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors : A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL : Phase I Study of the Administration of T Lymphocytes Co-Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma : Phase I Study of Autologous CAR T-Cells Targeting the CD138 Antigen for Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma : A Phase I Study of Autologous Activated T-cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch in Subjects With Relapsed/Refractory B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma : A Phase I Study of Autologous Activated T-Cells Expressing a 2nd Generation GD2 Chimeric Antigen Receptor, IL-15, and iCaspase9 Safety Switch Administered To Patients With Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST) : Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[790]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
7.900
Aufsätze
7.900
E-Artikel
7.900
E-Ressourcen
Zeitschriftentitel
5.320
ClinicalTrials.gov
2.580
WHO International Clinical Trials Registry Plat...
Thema
7.900
610
Phase: Phase 1
Recruitment Status: Recruiting
7.898
Study Type: Interventional
890
Neoplasms
329
Carcinoma
322
Lymphoma
314
Leukemia
183
Carcinoma, Non-Small-Cell Lung
168
Leukemia, Myeloid, Acute
165
Lung Neoplasms
161
Leukemia, Myeloid
156
Lymphoma, B-Cell
156
Lymphoma, Non-Hodgkin
151
Multiple Myeloma
148
Breast Neoplasms
148
Recurrence
138
Neoplasms, Plasma Cell
127
Precursor Cell Lymphoblastic Leukemia-Lymphoma
116
Leukemia, Lymphoid
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6.942
2020-
958
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7.868
Englisch
32
Unbestimmt
Haven't found what you're looking for?
Wird geladen...